Land: Australia
Språk: engelsk
Kilde: Department of Health (Therapeutic Goods Administration)
Carbimazole
Link Medical Products Pty Ltd T/A Link Pharmaceuticals
Medicine Registered
NEO-MERCAZOLE (neo-mer-caz-ol) _contains the active ingredient:_ _ carbimazole _ _ _ CONSUMER MEDICINE INFORMATION _ _ Neo-Mercazole - Consumer Medicine Information – version 3.0 1 WHAT IS IN THIS LEAFLET This leaflet answers some common questions about Neo- Mercazole tablets. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risks of you taking Neo-Mercazole against the benefits they expect it will have for you. IF YOU HAVE ANY CONCERNS ABOUT TAKING THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET WITH THE MEDICINE. You may need to read it again. WHAT NEO-MERCAZOLE IS USED FOR Neo-Mercazole contains the active ingredient Carbimazole. Neo-Mercazole is used to treat hyperthyroidism or overactive thyroid gland (a condition where the thyroid gland produces too much thyroid hormones). Neo-Mercazole belongs to a group of medicines called anti- hyperthyroidism agents. These medicines work by reducing the production of thyroid hormones. There are different types of medicines used to treat hyperthyroidism. Your doctor, however, may have prescribed Neo-Mercazole for another purpose. ASK YOUR DOCTOR IF YOU HAVE ANY QUESTIONS ABOUT WHY NEO- MERCAZOLE HAS BEEN PRESCRIBED FOR YOU. Neo-Mercazole is not addictive. This medicine is available only with a doctor's prescription. BEFORE YOU TAKE NEO- MERCAZOLE _WHEN YOU MUST NOT TAKE IT _ DO NOT TAKE NEO-MERCAZOLE IF: 1. YOU HAVE HAD AN ALLERGIC REACTION TO NEO-MERCAZOLE OR ANY INGREDIENTS LISTED AT THE END OF THIS LEAFLET 2. YOU HAVE A PREVIOUS HISTORY OF ADVERSE REACTIONS TO CARBIMAZOLE 3. YOU HA Les hele dokumentet
- 1 - PRODUCT INFORMATION NEO-MERCAZOLE (carbimazole) NAME OF MEDICINE Carbimazole (CAS registry number: 22232-54-8) The chemical name for carbimazole is ethyl 3–methyl-2-thioxo-4-imidazoline-1-carboxylate. The chemical formula is C 7 H 10 N 2 O 2 S. The molecular weight is 186.2. DESCRIPTION Carbimazole is a white or yellowish-white crystalline powder, slightly soluble in water, soluble in alcohol and in acetone. NEO-MERCAZOLE is available as a pink tablet containing the following excipients: lactose, sucrose, starch-maize, magnesium stearate, talc, , acacia, ferric oxide food grade (77491), and gelatin. PHARMACOLOGY NEO-MERCAZOLE is an anti-thyroid agent. NEO-MERCAZOLE is believed to exert its antithyroid effect by 'blocking' the organic binding of iodine through inhibition of the iodination of tyrosine. It is also thought to have some action on peroxidase which is required as a catalyst in the synthesis of thyroxine by the thyroid gland. It does not affect the uptake of iodine by the thyroid gland and this is of vital importance in the treatment of thyrotoxicosis with radioactive iodine or with a combination of radioiodine and NEO-MERCAZOLE, and also in preparation of patients for operation. Carbimazole is completely and rapidly metabolised to methimazole and it is the latter that is responsible for the antithyroid activity of carbimazole. Carbimazole is rapidly absorbed from the gastrointestinal tract. The mean peak plasma concentration of methimazole is reported to occur one hour after a single dose of carbimazole. The plasma half-life of methimazole is reported as between 3 and 6 hours. Most of an orally administered dose of carbimazole is excreted in the urine. Less than 12% may be excreted as unchanged methimazole. N Les hele dokumentet